Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group (Q70955349)
scientific article published on 01 November 1995
Language:
Current Data About Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group
(P31) (Q13442814)
(P248)
(P698) 8583134
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583134%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 15, 2019

(P304) 487-496
(P248)
(P698) 8583134
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583134%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 15, 2019

(P407) (Q1860)

(P433) 5
(P248)
(P698) 8583134
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583134%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 15, 2019

(P478) 23
(P248)
(P698) 8583134
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583134%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 15, 2019

(P577) Wednesday, November 1, 1995
(P248)
(P698) 8583134
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583134%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 15, 2019

(P921) (Q6934595)
(P887)

(Q408)

(Q154869)
(P887)

(Q55779873)
(P887)

(Q62019625)
(P887)

(P1433) (Q15724402)
(P248)
(P698) 8583134
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583134%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 15, 2019

(P1476) "Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group" (language: en)
(P248)
(P698) 8583134
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583134%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 15, 2019

(P2093) R Lin
(P1545) 1
(P248)
(P698) 8583134
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583134%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 15, 2019

E Roach
(P1545) 2
(P248)
(P698) 8583134
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583134%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 15, 2019

M Zimmerman
(P1545) 3
(P248)
(P698) 8583134
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583134%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 15, 2019

S Strasser
(P1545) 4
(P248)
(P698) 8583134
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583134%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 15, 2019

G C Farrell
(P1545) 5
(P248)
(P698) 8583134
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8583134%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 15, 2019

other details
description scientific article published on 01 November 1995

External Links
(P356) 10.1016/0168-8278(95)80052-2
(P698) 8583134